MNKD Competitors & Alternatives
Compare MannKind Corp with similar stocks in the same industry
Biotechnology
MNKD
Main Stock$4.04
Tradestie Score
51
Market Cap
$1.65B
Revenue Growth
0.2%
Analyst Upside
+88.0%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$40.59
|
$1.32B | - | 65 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.16
|
$1.29B | 119.1 | 61 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.46
|
$1.29B | - | 50 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.14
|
$1.29B | - | 52 | Compare |
|
ZYME
Zymeworks Inc.
|
$24.94
|
$1.28B | - | 54 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$5.77
|
$1.27B | - | 55 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$43.95
|
$1.26B | - | 61 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$4.97
|
$1.22B | - | 63 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$5.17
|
$1.18B | - | 59 | Compare |
More MNKD Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry